Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MS pill 'available within months'

  • 1 Comment

People with multiple sclerosis (MS) could be offered a new treatment within a few months, it has been announced.

The first pill for MS has been approved by European experts, paving the way for an EU-wide licence.

Gilenya, which is already sold in the US and Russia, provides the first daily pill alternative to injected MS treatments.

The Committee for Medicinal Products for Human Use (CHMP), made up of experts from the European Medicines Agency (EMA), has recommended that the EU regulator approve the drug.

The Swiss-based manufacturer of the drug, Novartis, said a licence allowing Gilenya to be marketed in the UK was expected “in the next few months”.

The announcement has been welcomed by the MS Society.

The group’s policy and research director Dr Jayne Spink said: “The news about Gilenya is great for people with MS. The availability of a tablet to treat the condition will give people more choice and for many will come as a welcome relief from frequent injections.

“All being well, Gilenya could be available for people with MS later this year.”

The CHMP said Gilenya was appropriate for patients with two serious forms of relapsing-remitting MS.

Currently many patients with the disease have to self-inject with drugs such as beta interferon or travel to hospital for treatment.

  • 1 Comment

Readers' comments (1)

  • It is great news that AT LAST we are catching up with Russia and US.Too many people with MS develop significant disability in this country that can be delayed with appropriate treatment available in other countries.
    I would love to know of any treatments suitable for primary progressive MS, which my son suffers from.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs